...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

I sent an email to info@zenithepigenetcs.com a few days ago,,asking if we shoud expect data from any of these trials in 2024. No response yet,,and based on the historic disrespect both these companies have for their shareholders we all should anticipate getting is a meme of the middle finger in return!!,,Sad,,,but true!!!

Share
New Message
Please login to post a reply